Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-25 @ 4:05 AM
NCT ID:
NCT03898102
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with mCRC who have been previously treated with, or are not considered candidates for, other locally approved standard treatment(s) and for whom the decision has been made per investigator's routine treatment practice to prescribe regorafenib
* Ability to understand and willingness to sign written Informed Consent Form (ICF)
Exclusion Criteria:
* Patients participating in an investigational program with interventions outside of routine clinical practice
* Patients with baseline Zinc level above 120 ug/dL
* Patients with known allergy to Zinc supplementation
* Pregnancy
* Patients who are unsuitable for study participation, based on investigator's discretion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT03898102
Study Brief:
Protocol Section:
NCT03898102